Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by malibukion Apr 21, 2017 11:47am

148 Views

Post# 26148826

option exercise rule

it is confirmed that 90 days rule applies for options after job termination (announcement of Attila made on 15th of Feb - termination probably before).

But no comment specifically for Attila's case. So +90 days may be significant or not. Just keep it on mind.

GL

M.

Bullboard Posts

This junior mining stock offers billions in market exposure